These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16925979)

  • 1. WLIP and tolaasin I, lipodepsipeptides from Pseudomonas reactans and Pseudomonas tolaasii, permeabilise model membranes.
    Coraiola M; Lo Cantore P; Lazzaroni S; Evidente A; Iacobellis NS; Dalla Serra M
    Biochim Biophys Acta; 2006 Nov; 1758(11):1713-22. PubMed ID: 16925979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological characterization of white line-inducing principle (WLIP) produced by Pseudomonas reactans NCPPB1311.
    Lo Cantore P; Lazzaroni S; Coraiola M; Dalla Serra M; Cafarchia C; Evidente A; Lacobellis NS
    Mol Plant Microbe Interact; 2006 Oct; 19(10):1113-20. PubMed ID: 17022175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolaasins A--E, five new lipodepsipeptides produced by Pseudomonas tolaasii.
    Bassarello C; Lazzaroni S; Bifulco G; Lo Cantore P; Iacobellis NS; Riccio R; Gomez-Paloma L; Evidente A
    J Nat Prod; 2004 May; 67(5):811-6. PubMed ID: 15165142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico study of the ion channel formed by tolaasin I produced by Pseudomonas tolaasii.
    Jo G; Hwang D; Lee S; Woo Y; Hyun J; Yong Y; Kang K; Kim DW; Lim Y
    J Microbiol Biotechnol; 2011 Oct; 21(10):1097-100. PubMed ID: 22031037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two types of ion channel formation of tolaasin, a Pseudomonas peptide toxin.
    Cho KH; Kim YK
    FEMS Microbiol Lett; 2003 Apr; 221(2):221-6. PubMed ID: 12725930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of compounds exhibiting inhibitory activity toward the Pseudomonas tolaasii toxin tolaasin I using in silico docking calculations, NMR binding assays, and in vitro hemolytic activity assays.
    Lee Y; Woo Y; Lee S; Kang K; Yong Y; Kim JK; Kim KP; Kim MH; Kim YK; Lim Y
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4321-4. PubMed ID: 19500984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure, conformation and biological activity of a novel lipodepsipeptide from Pseudomonas corrugata: cormycin A.
    Scaloni A; Dalla Serra M; Amodeo P; Mannina L; Vitale RM; Segre AL; Cruciani O; Lodovichetti F; Greco ML; Fiore A; Gallo M; D'Ambrosio C; Coraiola M; Menestrina G; Graniti A; Fogliano V
    Biochem J; 2004 Nov; 384(Pt 1):25-36. PubMed ID: 15196052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adsorption of Tolaasins, the Toxins Behind Mushroom Bacterial Blotch, by Microbacterium spp. is Insufficient for Its Detoxification.
    Tomita S; Hirayasu A; Kajikawa A; Igimi S; Shinohara H; Yokota K
    Curr Microbiol; 2020 Jun; 77(6):910-917. PubMed ID: 31965226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of a pore-forming peptide toxin, tolaasin, produced by Pseudomonas tolaasii 6264.
    Cho KH; Kim ST; Kim YK
    J Biochem Mol Biol; 2007 Jan; 40(1):113-8. PubMed ID: 17244491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a gene cluster encoding three high-molecular-weight proteins, which is required for synthesis of tolaasin by the mushroom pathogen Pseudomonas tolaasii.
    Rainey PB; Brodey CL; Johnstone K
    Mol Microbiol; 1993 May; 8(4):643-52. PubMed ID: 8332057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperature-dependent hemolytic activity of membrane pore-forming peptide toxin, tolaasin.
    Cho KH; Wang HS; Kim YK
    J Pept Sci; 2010 Feb; 16(2):85-90. PubMed ID: 19960443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct lipopeptide production systems for WLIP (white line-inducing principle) in Pseudomonas fluorescens and Pseudomonas putida.
    Rokni-Zadeh H; Li W; Yilma E; Sanchez-Rodriguez A; De Mot R
    Environ Microbiol Rep; 2013 Feb; 5(1):160-9. PubMed ID: 23757145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction of lipodepsipeptide toxins from Pseudomonas syringae pv. syringae with biological and model membranes: a comparison of syringotoxin, syringomycin, and two syringopeptins.
    Dalla Serra M; Fagiuoli G; Nordera P; Bernhart I; Della Volpe C; Di Giorgio D; Ballio A; Menestrina G
    Mol Plant Microbe Interact; 1999 May; 12(5):391-400. PubMed ID: 10226372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactive and structural metabolites of pseudomonas and burkholderia species causal agents of cultivated mushrooms diseases.
    Andolfi A; Cimmino A; Cantore PL; Iacobellis NS; Evidente A
    Perspect Medicin Chem; 2008 May; 2():81-112. PubMed ID: 19787100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and functional characterization of cyclic lipopeptide white-line-inducing principle (WLIP) production by rice rhizosphere isolate Pseudomonas putida RW10S2.
    Rokni-Zadeh H; Li W; Sanchez-Rodriguez A; Sinnaeve D; Rozenski J; Martins JC; De Mot R
    Appl Environ Microbiol; 2012 Jul; 78(14):4826-34. PubMed ID: 22544260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Draft Genome Sequence of Pseudomonas fluorescens LMG 5329, a White Line-Inducing Principle-Producing Bioindicator for the Mushroom Pathogen Pseudomonas tolaasii.
    Ghequire MG; Rokni-Zadeh H; Zarrineh P; De Mot R
    Genome Announc; 2013 Jul; 1(4):. PubMed ID: 23887909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A left-handed alpha-helix containing both L- and D-amino acids: the solution structure of the antimicrobial lipodepsipeptide tolaasin.
    Jourdan F; Lazzaroni S; Méndez BL; Lo Cantore P; de Julio M; Amodeo P; Iacobellis NS; Evidente A; Motta A
    Proteins; 2003 Sep; 52(4):534-43. PubMed ID: 12910453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for genotypic differences between the two siderovars of Pseudomonas tolaasii, cause of brown blotch disease of the cultivated mushroom Agaricus bisporus.
    Munsch P; Johnstone K; Alatossava T
    Microbiol Res; 2002; 157(2):93-102. PubMed ID: 12002406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary description of biocidal (syringomycin) activity in fluorescent plant pathogenic Pseudomonas species.
    Hu FP; Young JM; Fletcher MJ
    J Appl Microbiol; 1998 Aug; 85(2):365-71. PubMed ID: 9750309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fuscopeptins, antimicrobial lipodepsipeptides from Pseudomonas fuscovaginae, are channel forming peptides active on biological and model membranes.
    Coraiola M; Paletti R; Fiore A; Fogliano V; Dalla Serra M
    J Pept Sci; 2008 Apr; 14(4):496-502. PubMed ID: 18085513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.